Sugi Predict

Sugi Predict / Compounds / SCHEMBL29425567

SCHEMBL29425567

SCHEMBL29425567

CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)[C@@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@@H]([C@H](O)[C@H](O)CO)O2)[C@H]1O

nearest known ligand 0.79

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SELP P16109 2/20 0.72
▸ SELL P14151 1/20 0.72
▸ SELE P16581 5/20 0.64
▸ SIGLEC7 Q9Y286 6/20 0.63
▸ MAG P20916 6/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31701537 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL30649697 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL31700312 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL31701558 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL30651255 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL29483500 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL31700325 1.00 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL30653052 0.99 SELP (0.72) SELPSELLSELESIGLEC7MAG
SCHEMBL31701050 0.99 SELP (0.70) SELPSELLSELESIGLEC7MAG
SCHEMBL31702119 0.99 SELP (0.70) SELPSELLSELESIGLEC7MAG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4195953-A1 HUMAN MILK OLIGOSACCHARIDE COMPOSITIONS FOR USE WITH BACTERIOTHERAPIES Prolacta Bioscience, Inc. (US) 2023-06-21 — — EP claimed
WO-2022036225-A1 HUMAN MILK OLIGOSACCHARIDE COMPOSITIONS FOR USE WITH BACTERIOTHERAPIES PROLACTA BIOSCIENCE, INC. (US) 2022-02-17 — — WO claimed
EP-4281181-A1 TOPICAL HUMAN MILK FORMULATIONS Prolacta Bioscience, Inc. (US) 2023-11-29 — — EP disclosed
EP-4277634-A1 SYNBIOTIC TREATMENT REGIMENS Prolacta Bioscience, Inc. (US) 2023-11-22 — — EP disclosed
WO-2022225779-A1 METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING ABBOTT LABORATORIES (US) 2022-10-27 — — WO disclosed
WO-2022159705-A1 TOPICAL HUMAN MILK FORMULATIONS PROLACTA BIOSCIENCE, INC. (US) 2022-07-28 — — WO disclosed
WO-2022155201-A1 SYNBIOTIC TREATMENT REGIMENS PROLACTA BIOSCIENCE, INC. (US) 2022-07-21 — — WO disclosed
CN-114364389-A Compositions and methods for treating inflammatory and immune diseases 普罗莱克塔生物科学公司 2022-04-15 — — CN disclosed
Send feedback